Overview
- Consolidated revenue increased about 1% to roughly $1.64 billion, with sales volume up 1% to 1,096 thousand metric tons.
- EBITDA rose 2% to $297.7 million and net income advanced 3%, reflecting stable profitability despite U.S. softness.
- U.S. sales fell 5% to $874 million on weaker consumer confidence, lower institutional volume and targeted promotions, while the Better for You line maintained steady growth.
- Europe delivered a 15% sales increase to $135.5 million on a more profitable mix and retail expansion, and Asia & Oceania grew 6% to $72.5 million.
- Net debt declined by $37 million to $1.807 billion and capex reached $44 million, as GIMSA reported steady volumes with temporary raw‑material cost pressure.